Skip to content

NXXT NXXT Deferred Tax Assets Capitalized Research Expenditures

Deferred Tax Assets Capitalized Research Expenditures at other companies

Nuvation Bio logo
Nuvation BioNUVB
$78.79M-19.0%
Wrap Technologies logo
Wrap TechnologiesWRAP
$1.14M-41.1%
SB Financial Group logo
SB Financial GroupSBFG
$102K+13.3%
MAG
MagneraMAGN
$10M+11.1%
OFL
Omega FlexOFLX
$423K-12.8%
CVD Equipment Corp. logo
CVD Equipment Corp.CVV
$531K-51.6%

Other financials

Income statement

See full
Revenue$21.1M+29.4%
Gross profit$1.7M+230%
Operating income-$10.1M-75.4%
Net income-$10.7M-22.1%
EPS (diluted)-$0.07+95.6%

Balance sheet

See full
Cash & equivalents$208.0K-90.2%
Total debt$3.4M+4,849%
Total equity-$19.6M-252%
Total assets$12.3M-52.9%

Cash flow

See full
Operating cash flow-$2.1M+62.8%
CapEx$5.7M+26,892%
Free cash flow-$7.2M-490%

Valuation

See full
Market cap$55.34M-82.7%
Enterprise value$58.5M-81.6%
P/S0.6×-5.8×

Profitability

See full
Gross margin9.4%+4.4pp
Operating margin-86%-1,407pp
Net margin-101.1%+60.1pp
FCF margin-43%

Returns & leverage

See full
Return on equity-1,208.8%-1,564pp
Debt / equity0.3×-56.1×
Current ratio0.2×0.0×

Where this comes from

Reported directly by NXXT in its filing.

Tagged under the XBRL concept NXXT:DeferredTaxAssetsCapitalizedResearchExpenditures.

The official record: NXXT’s 10-K/A, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about NXXT's deferred tax assets capitalized research expenditures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NXXT's deferred tax assets capitalized research expenditures?
NXXT (NXXT) reported deferred tax assets capitalized research expenditures of $367.23K in Q4 2025.
What is the long-term trend for NXXT's deferred tax assets capitalized research expenditures?
Over 2 years (2023 to 2025), NXXT's deferred tax assets capitalized research expenditures has grown at a 0.0% compound annual growth rate (CAGR), from $367K to $367.23K.
What does deferred tax assets capitalized research expenditures mean?
This represents the tax benefit arising from the capitalization of research and development expenditures for tax reporting purposes. It reflects the future tax savings expected when these capitalized costs are amortized or deducted over time. Investors monitor this to understand the tax shield generated by the company's innovation investments.